The Developing Story of Predictive Biomarkers in Colorectal Cancer
Colorectal cancer (CRC) is the third most common malignancy worldwide. Surgery remains the most important treatment for non-metastatic CRC, and the administration of adjuvant chemotherapy depends mainly on the disease stage, which is still the strongest prognostic factor. A refined understanding of...
Main Authors: | Stergios Boussios, Mehmet Akif Ozturk, Michele Moschetta, Afroditi Karathanasi, Nikolaos Zakynthinakis-Kyriakou, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Nicholas Pavlidis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/9/1/12 |
Similar Items
-
Regulatory T Cells in Colorectal Cancer: From Biology to Prognostic Relevance
by: Dimitrios Mougiakakos
Published: (2011-03-01) -
Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients
by: Takehito Yamamoto, et al.
Published: (2021-07-01) -
Cancer-Associated Thrombosis: A New Light on an Old Story
by: Sidrah Shah, et al.
Published: (2021-05-01) -
Tumor budding in colorectal adenocarcinoma using cytokeratin 20 immunostaining
by: Chaitra N, et al.
Published: (2023-12-01) -
Expression of Spermine Oxidase Is Associated with Colorectal Carcinogenesis and Prognosis of Patients
by: Sooyoun Kim, et al.
Published: (2022-03-01)